Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

04 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/04/3180455/0/en/Enara-Bio-s-DARKFOX-Discovery-Propels-ENA101-the-First-Ever-Bispecific-T-Cell-Engager-Targeting-a-Cancer-Specific-Dark-Antigen-into-IND-Enabling-Studies.html

06 Oct 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-10-06/enara-bio-to-reveal-darkfox-a-novel-cancer-specific-dark-antigen-with-broad-ranging-therapeutic-potential-in-oral-presentation-at-sitc-2025

03 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/03/3160977/0/en/Enara-Bio-to-Reveal-DARKFOX-a-Novel-Cancer-Specific-Dark-Antigen-with-Broad-Ranging-Therapeutic-Potential-in-Oral-Presentation-at-SITC-2025.html

01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072084/0/en/Enara-Bio-Strengthens-Senior-Leadership-with-Key-Executive-and-Board-Appointments-Alongside-Acceleration-of-Multiple-T-Cell-Engager-Programs.html

03 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/03/2957454/0/en/Enara-Bio-raises-32-5-million-Series-B-financing-to-advance-first-in-class-pipeline-of-TCR-based-immunotherapies-targeting-novel-Dark-Antigens.html

04 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/04/2803914/0/en/Boehringer-Ingelheim-licenses-multiple-Dark-Antigens-from-Enara-Bio-to-develop-off-the-shelf-immunotherapies-for-non-small-cell-lung-cancer-NSCLC.html
ABOUT THIS PAGE